The relationship between prolactin levels, sleep disorders and the effectiveness of glycaemia correction in patients with hypertension and type 2 diabetes mellitus

Abstract

Objective — to assess sleep disorders in patients with hypertension and type 2 diabetes mellitus and to establish the role of prolactin in the formation of these changes. Materials and methods. The study included 63 patients with hypertension and type 2 diabetes mellitus. All patients were evaluated for sleep disorders using the Epworth Daytime Sleepiness Scale and the International Classification of Sleep Disorders Scale (International Academy of Sleep Disorders, Issue 3, 2014). The levels of plasma lipids, blood glucose level, glycosylated hemoglobin as well as anthropometric parameters were measured in all patients. Prolactin was determined using immunosorbent analysis using fixed enzymes (principle conjugated by ELISA peroxidase) on an Immunochem-2100 analyzer. Results and discussion. Patients were divided into four groups depending on the prolactin level according to quartiles. Group 1 included 14 patients, with prolactin levels from 97.1 to 211.5; group 2 included 18 patients with prolactin levels from 221.6 to 271.2; group 3 included 19 patients with prolactin levels from 271.3 to 422.8, and group 4 consisted of 11 patients with prolactin levels of 422.9—563.5. It has been established that patients with low prolactin level (groups I—II) were more likely to experience early awakenings in comparison with patients with high level of prolactin (groups III—IV). Patients with low prolactin level had significantly higher Epworth score. The strong inverse correlation has been found between prolactin levels and metformin dose (Pearson correlation coefficient –0.427, p = 0.001). Conclusions. Patients with type 2 diabetes mellitus, hypertension, and sleep disorders (high score on the Epworth scale and early awakenings) had significantly lower prolactin levels than patients without sleep disorders.

Authors and Affiliations

O. О. Buriakovska, G. S. Isayeva

Keywords

Related Articles

Labial herpes: view on the problem, options for optimizing topical therapy

Herpes virus infection holds a special place in the structure of viral diseases due to its high prevalence in the population, a variety of clinical forms, as well as the steadily growing number of infected people. Labial...

Idiopathic inflammatory myopathies: difficulties of diagnosis

The rapid development of basic researches in medicine in the last decade allowed a new approach to the etiopathogenesis of a number of diseases, which, in particular, include inflammatory myopathies. Idiopathic inflammat...

Significance of non-invasive assessment of the enhancing left ventricle filling pressure in patients with arterial hypertension, left ventricle hypertrophy, symptoms of heart failure and the preserved ejection fraction in real life

Objective — to estimate left ventricle filling pressure (LVFP), as indicator of heart failure (HF), in patients with arterial hypertension (AH), symptoms and signs of HF, preserved left ventricle (LV) ejection fraction (...

The effectiveness of differentiated therapy with renin-angiotensin-aldosterone blockers in patients with heart failure and type 2 diabetes mellitus

Objective — to evaluate the efficacy of differentiated therapy for ACE inhibitors and ARB II in patients with HFpEF and type 2 diabetes mellitus (DM 2), depending on the M235T polymorphism of the ATG gene. Materials and...

Acetylsalicylic acid in the cardiological practice: the focus on enterotoxicity

Acetylsalicylic acid (ASA) is one of the most commonly prescribed drugs all over the world. The constant ASA administration results in the considerable side effects, especially associated with the gastrointestinal tract....

Download PDF file
  • EP ID EP666931
  • DOI 10.30978/UTJ2019-3-28
  • Views 99
  • Downloads 0

How To Cite

O. О. Buriakovska, G. S. Isayeva (2019). The relationship between prolactin levels, sleep disorders and the effectiveness of glycaemia correction in patients with hypertension and type 2 diabetes mellitus. Український терапевтичний журнал, 0(3), 28-34. https://europub.co.uk./articles/-A-666931